https://www.zacks.com/stock/news/2311202/caesars-entertainment-czr-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311202
Jul 29, 2024 - Increased competition, construction disruptions and higher expenses are likely to have affected Caesars Entertainment's (CZR) Q2 performance.
zc:8311191514263351146
0
https://www.zacks.com/stock/news/2311061/gildan-activewear-gil-to-post-q2-earnings-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311061
Jul 29, 2024 - Gildan Activewear's (GIL) concentrated efforts on key product lines, particularly in the activewear segment, are expected to have contributed to top-line growth in the second quarter.
zc:-1025029765699297373
0
https://www.zacks.com/stock/news/2311110/janus-henderson-jhg-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311110
Jul 29, 2024 - Janus Henderson's (JHG) second-quarter 2024 results are likely to benefit from favorable equity market performance. Yet, a rise in costs is likely to be a spoilsport.
zc:6588030255537100059
0
https://www.zacks.com/stock/news/2311049/what-awaits-biogen-biib-in-q2-earnings-post-leqembi-setback?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311049
Jul 29, 2024 - Biogen's (BIIB) sales in the second quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have been hurt by increased competition.
zc:1517175659739374603
0
https://seekingalpha.com/article/4707517-att-moving-to-hold-post-q2-2024-results?source=feed_all_articles
Jul 28, 2024 - Financial analysis of AT&T: Q2-2024 results were positive, but we have moved to a Hold rating.
0
sa:5749642168986434323
0
https://www.zacks.com/stock/news/2310289/zebra-technologies-zbra-to-post-q2-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310289
Jul 26, 2024 - Zebra Technologies' (ZBRA) Q2 results are likely to benefit from the solid demand for services, software and RFID products. Weakness in the printing end market is likely to hurt its results.
zc:9024878721038038505
0
https://www.zacks.com/stock/news/2310288/newell-s-nwl-q2-earnings-beat-mark-soft-core-sales-hurt?cid=CS-ZC-FT-analyst_blog|earnings_article-2310288
Jul 26, 2024 - Newell (NWL) reports a sales decline in second-quarter 2024, owing to a core sales drop of 4.2% year over year.
zc:5570870547070916536
0
https://www.zacks.com/stock/news/2310281/xylem-xyl-gears-up-to-post-q2-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310281
Jul 26, 2024 - Xylem's (XYL) second-quarter 2024 results are likely to gain from strength across its smart metering and other applications end markets despite weakness in the building solutions end market.
zc:2695229441342620523
0
https://www.zacks.com/stock/news/2310269/match-group-mtch-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310269
Jul 26, 2024 - Match Group's (MTCH) second-quarter results will likely reflect strength in Tinder, Hinge and Azar. However, weakening demand in the United States might have been a concern.
zc:-2274162648464554500
0
https://www.zacks.com/stock/news/2310274/ipg-photonics-ipgp-to-post-q2-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310274
Jul 26, 2024 - IPG Photonics' (IPGP) second-quarter 2024 results are likely to suffer from weakness in cutting and marking applications and continued economic uncertainty.
zc:-1463276614489945081
0